Previous reports demonstrated that transplantation of gene-modified human MSCs overepressing GDNF, BDNF, or VEGF after cerebral ischemia reduce infarct volume and ameliorate neurological deficits [40], [41], [42]. Here, GDNF is linked to brain ischemia.